Skip to main content

Edith Perez

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Edith Perez

Bolt Biotherapeutics, Inc. reported in an 8-K filed May 14, 2024 that Edith Perez resigned as Chief Medical Officer, effective May 15, 2024. The proxy statement of Bolt Biotherapeutics, Inc. reports total compensation of $882,144 for Edith Perez in fiscal 2024, including a base salary of $327,665. Disclosed compensation is on record for 5 fiscal years.

“Edith A. Perez, M.D. is stepping down as the Company's Chief Medical Officer of the Company, effective as of May 15, 2024, as the Company is eliminating the position of Chief Medical Officer.”
Bolt Biotherapeutics, Inc. Form 8-K, filed May 14, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Bolt Biotherapeutics, Inc. (BOLT) $327,665 $882,144
2023 Bolt Biotherapeutics, Inc. (BOLT) $486,640 $982,715
2022 Bolt Biotherapeutics, Inc. (BOLT) $467,920 $1,137,019
2021 Bolt Biotherapeutics, Inc. (BOLT) $435,000 $2,128,771
2020 Bolt Biotherapeutics, Inc. (BOLT) $300,000 $1,268,840

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.